Biologics Market Size to Reach USD 679.56 Billion by 2030, Driven by Monoclonal Antibodies and Asia-Pacific Expansion

Mordor Intelligence has published a new report on the "Biologics Market" offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction to Biologics Market Size

The Biologics Market Size is estimated at USD 412.68 billion in 2025, and is expected to grow to USD 679.56 billion by 2030, registering a CAGR of 10.49% during this period.

Biologics are becoming more central to modern healthcare as treatments for cancer, autoimmune disorders, and other chronic diseases demand advanced therapies. With regulatory support, increasing approvals, and rising investment in research, drug firms are pushing biologics from experimental phases into standard therapeutic use. At the same time, biosimilars are entering markets, which is helping widen access and lower costs.

North America remains the largest region for biologics, supported by strong infrastructure, funding, and market adoption. But Asia-Pacific is predicted to post the fastest growth, as more countries in that region increase their production capacity, regulatory clarity, and clinical trial activity.

Report Overview: https://www.mordorintelligence.com/industry-reports/biologics-market?utm_source=openpr

Key Trends in the Biologics Market

Here are the Biologics Market Trends shaping how this market is growing:

Strong demand for monoclonal antibodies
Monoclonal antibodies currently leads in market share and are heavily used in oncology and autoimmune disease treatment. Their clinical success and wide acceptance make them a core contributor to market size.

Growth of gene-based and cell therapies
Gene-based biologics are growing at higher rates. As more gene therapies get regulatory approval, they are expected to become a larger part of the treatment landscape.

Larger role for biosimilars
To control costs, many healthcare systems are turning to biosimilars once originator biologic patents expire. This helps reduce spending and increases competition, especially in established markets.

Use of modern manufacturing technology
Single-use bioreactors are a major manufacturing tool now, holding a large share of production. At the same time, continuous perfusion platforms are being adopted faster, helping to meet demand more flexibly.

Regulatory support and designations
Regulatory bodies are offering faster pathways and special designations for biologics, especially in areas of unmet need. This helps companies move therapies more quickly from development into clinical use.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/biologics-market?utm_source=openpr



Market Segmentation of the Biologics Market

The Biologics Market can be divided into segments by product type, application, manufacturing technology, and geography. Key segments are:

By Product Type

Monoclonal Antibodies

Gene-based Biologics

By Application

Oncology

Autoimmune Disorders and Other Therapeutic Areas

By Geography

North America

Asia-Pacific

Europe and other regions

This segmentation shows where market share is strongest now (monoclonals, oncology, established regions) and where growth is expected (gene therapies, Asia-Pacific, new tech platforms).

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players in the Biologics Market

Amgen, Inc.

Eli Lilly and Company

GlaxoSmithKline PLC

Abbvie Inc.

F. Hoffmann- La Roche AG

These firms are competing on several fronts: quality, production scale, regulatory compliance, cost, and speed of bringing therapies to market. As demand increases, especially for complex biologics, those who can deliver reliably at lower cost will gain more share.

To know more about the major players in the market, visit: https://www.mordorintelligence.com/industry-reports/biologics-market/companies?utm_source=openpr

Conclusion on the Biologics Market

The Biologics Market Growth is expected to remain strong, many factors are aligning for this growth: rising rates of cancer and other chronic diseases, better regulatory pathways, broad uptake of biosimilars, and expanded manufacturing capacity. The shift toward gene-based biologics and advanced manufacturing technologies will bring more therapeutic options into reach.

Asia-Pacific is likely to become a major contributor by 2030, not just in demand but also in production, driven by emerging biotech hubs and favorable policy. Meanwhile, North America and Europe will continue to be important markets due to existing infrastructure, funding, and clinical adoption.

Industry Related Reports

Spine Biologics Market: The Spine Biologics Market Report is Segmented by Product Type (Bone Graft Substitutes [Bone Morphogenetic Proteins and More], Spinal Allografts [Machined Structural Allografts and More], Cell-Based Matrices, and More), Surgery Type (Anterior Cervical Discectomy & Fusion and More), End-User (Hospitals and More), and Geography (North America, Europe, and More).
Get more insights: https://www.mordorintelligence.com/industry-reports/spine-biologics-market?utm_source=openpr

Asia Pacific Wound Care Biologics Market: The Asia Pacific Wound Care Biologics Market report segments the industry into By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns), By End User (Hospitals/Clinics, Ambulatory Surgical Centers, Other End Users), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific).
Get more insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-wound-care-biologics-market?utm_source=openpr

Veterinary Biologics Market: The Veterinary Biologics Market Report is Segmented by Product Type (Antisera & Immunoglobulins and More), Animal Type (Companion Animals, Livestock, Equine), Distribution Channel (Veterinary Hospitals and More), Technology (Live Attenuated and More), and Geography (North America, Europe, Asia-Pacific, and More).
Get more insights: https://www.mordorintelligence.com/industry-reports/veterinary-biologics-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.